Clicky

AbbVie Inc(4AB) News

Date Title
Jul 30 Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect
Jul 30 AbbVie Announces Positive Topline Results from Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata
Jul 30 Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL
Jul 30 Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever
Jul 30 AbbVie (ABBV) Reports Q2: Everything You Need To Know Ahead Of Earnings
Jul 29 AbbVie (ABBV) Files sNDA For Oral VENCLEXTA Combo Regimen In CLL Treatment
Jul 29 Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
Jul 29 AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
Jul 28 HS market forecast to reach $7.8bn across 7MM by 2034
Jul 28 Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
Jul 28 Pre-Q2 Earnings: Is AbbVie Stock a Portfolio Must-Have?
Jul 28 Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
Jul 28 2 Top Dividend Stocks to Buy Right Now and Hold Forever
Jul 28 Option Volatility And Earnings Report For July 28 – Aug 1
Jul 28 Guggenheim Reiterates a Buy Rating on AbbVie (ABBV) With a $216 PT
Jul 28 AbbVie (ABBV) Positioned for Growth With Strong Skyrizi, Rinvoq Sales, Says JPMorgan
Jul 26 The Smartest Dividend Stocks to Buy With $350 Right Now
Jul 26 Genmab A/S (GMAB) Opens U.S. Hub in New Jersey to Drive Global Growth
Jul 25 Mag 7 earnings, Fed meeting, PCE, jobs report: What to Watch
Jul 24 J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?